This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Oct;24(5):585-8.

doi: 10.1016/s0197-2456(03)00090-4.

Are all monitoring boundaries equally ethical?

Susan S Ellenberg¹

Affiliations

Affiliation

¹ Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA. ellenberg@cber.fda.gov

PMID: 14500055
DOI: 10.1016/s0197-2456(03)00090-4

Comment

Are all monitoring boundaries equally ethical?

Susan S Ellenberg. Control Clin Trials. 2003 Oct.

. 2003 Oct;24(5):585-8.

doi: 10.1016/s0197-2456(03)00090-4.

Author

Susan S Ellenberg¹

Affiliation

¹ Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA. ellenberg@cber.fda.gov

PMID: 14500055
DOI: 10.1016/s0197-2456(03)00090-4

No abstract available

PubMed Disclaimer

Comment on

A matter of life and death? The Heart Protection Study and protection of clinical trial participants.
Migrino RQ, Topol EJ; Heart Protection Study. Migrino RQ, et al. Control Clin Trials. 2003 Oct;24(5):501-5. doi: 10.1016/s0197-2456(03)00091-6. Control Clin Trials. 2003. PMID: 14500049 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information